Internal Medicine, Pulmonary Disease · Gainesville, GA
NPI
1093005852
Since 2011
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1240 Jesse Jewell Pkwy SE Ste 500
Gainesville, GA, 30501
Phone (770) 536-9864
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
4,392 services
Medicare patients, 2024
408
Average age 76
Drug cost, 2024
$4.2M
3,527 prescriptions
Company payments, 2025
$197K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivek S Sambhara was code 99214 (office e&m - established), 657 times for 331 patients. In total Vivek S Sambhara billed 4,392 services in 74 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 657 | 331 | $89.62 | $59K |
| 94664 E&M - Miscellaneous | Office | 449 | 215 | $12.01 | $5,393 |
| 36415 Venipuncture Blood Collection | Office | 249 | 194 | $8.58 | $2,138 |
| 80053 Clinical Chemistry | Office | 229 | 187 | $10.35 | $2,370 |
| 85025 Blood Count | Office | 223 | 188 | $7.55 | $1,685 |
| 94726 Pulmonary Function Testing | Office | 168 | 153 | $38.35 | $6,443 |
| 94729 Pulmonary Function Testing | Office | 168 | 153 | $38.01 | $6,386 |
| 94060 Pulmonary Function Testing | Office | 167 | 152 | $24.80 | $4,142 |
| 99497 Care Management/Coordination | Office | 143 | 142 | $59.26 | $8,475 |
| 99205 Office E&M - New | Office | 128 | 128 | $146.56 | $19K |
| 71250 CT/CTA - Chest | Office | 128 | 119 | $54.49 | $6,975 |
| 96372 Injection Administration | Office | 56 | 25 | $8.80 | $493 |
| 99406 Behavioral Health Services | Office | 46 | 32 | $13.72 | $631 |
| 86140 Clinical Chemistry | Office | 42 | 42 | $5.08 | $213 |
| 71046 X-ray - Chest | Office | 34 | 28 | $15.68 | $533 |
By year: 2022 $172K for 6,311 services; 2023 $186K for 5,857 services; 2024 $150K for 4,392 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 249 | 194 | $8.58 | $2,138 |
| 80053 Clinical Chemistry | 229 | 187 | $10.35 | $2,370 |
| 85025 Blood Count | 223 | 188 | $7.55 | $1,685 |
| 86140 Clinical Chemistry | 42 | 42 | $5.08 | $213 |
| 85651 Clinical Chemistry | 31 | 31 | $4.18 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Vivek S Sambhara prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,027 prescriptions and refills. In total Vivek S Sambhara wrote 3,527 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,027 | 1,590 | 247 | $1.0M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 482 | 718 | 173 | $22K |
| Montelukast Sodium Generic | 343 | 811 | 111 | $3,249 |
| Nucala Mepolizumab | 187 | 194 | 20 | $779K |
| Prednisone Generic | 157 | 164 | 110 | $399 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 106 | 188 | 39 | $115K |
| Breo Ellipta Fluticasone/Vilanterol | 98 | 186 | 30 | $71K |
| Ventolin Hfa Albuterol Sulfate | 92 | 122 | 39 | $8,189 |
| Ofev Nintedanib Esylate | 67 | 67 | Under 11 | $858K |
| Tezspire Tezepelumab-Ekko | 61 | 74 | 11 | $316K |
| Azithromycin Generic | 60 | 68 | 47 | $462 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 60 | 88 | 22 | $40K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 57 | 57 | 49 | $353 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 55 | 76 | 14 | $7,814 |
| Zafirlukast Generic | 50 | 68 | 12 | $4,095 |
Brand drugs: 2,373 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivek S Sambhara $197K ($197K in general payments such as food, travel and fees) from 14 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $70K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 47 | $70K |
| GlaxoSmithKline, LLC. GSK | 58 | $54K |
| AstraZeneca Pharmaceuticals LP AZN | 40 | $45K |
| Genzyme Corporation SNY | 29 | $27K |
| United Therapeutics Corporation UTHR | 2 | $247 |
| Electromed, Inc. ELMD | 6 | $202 |
| Verona Pharma, Inc. VRNA | 18 | $145 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99.95 |
| Amgen Inc. AMGN | 1 | $65.95 |
| Insmed, Inc. INSM | 2 | $43.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.